Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-25-001282
Accepted
2025-04-30 00:15:12
Documents
1
Effectiveness Date
2025-04-29

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 594
  Complete submission text file 9999999995-25-001282.txt   2072
Mailing Address 10531 4S COMMONS DRIVE SUITE 166-550 SAN DIEGO CA 92127
Business Address 1035 CAMBRIDGE STREET SUITE 18A CAMBRIDGE MA 02141 (617) 798-6700
Ernexa Therapeutics Inc. (Filer) CIK: 0000748592 (see all company filings)

EIN.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-286581 | Film No.: 25890606
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)